Barinthus Biotherapeutics BRNS
NASDAQ BRNS
$0.61 +0.01 (+1.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) EBT Margin (QoQ) (2020 - 2023)

Barinthus Biotherapeutics (BRNS) EBT Margin (QoQ) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Barinthus Biotherapeutics 25.01 Mn 25.01 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -346,899.00
Mar 31, 2023 -364,504.00
Dec 31, 2022 -48,144.00
Sep 30, 2022 3,583.00
Jun 30, 2022 7,519.00
Mar 31, 2022 -166.68 Mn
Dec 31, 2021 170.39 Mn
Sep 30, 2021 1.10 Mn
Jun 30, 2021 -4.40 Mn
Mar 31, 2021 -46,814.00
Dec 31, 2020 -356,045.00
Sep 30, 2020 80,376.00
Jun 30, 2020 -20,742.00